v3.25.4
Earnings Per Share (Tables)
 12 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Schedule of basic and diluted earnings per share, impact of two-class method
The following table summarizes the impact of the two-class method:
Years ended December 31,
(in millions, except per share data)202520242023
Basic EPS
Net earnings attributable to AbbVie Inc.$4,226 $4,278 $4,863 
Earnings allocated to participating securities40 40 43 
Earnings available to common shareholders$4,186 $4,238 $4,820 
Weighted average basic shares of common stock outstanding1,769 1,769 1,768 
Basic earnings per share attributable to AbbVie Inc.$2.37 $2.40 $2.73 
Diluted EPS
Net earnings attributable to AbbVie Inc.$4,226 $4,278 $4,863 
Earnings allocated to participating securities40 40 43 
Earnings available to common shareholders$4,186 $4,238 $4,820 
Weighted average shares of common stock outstanding1,769 1,769 1,768 
Effect of dilutive securities4 4 5 
Weighted average diluted shares of common stock outstanding1,773 1,773 1,773 
Diluted earnings per share attributable to AbbVie Inc.$2.36 $2.39 $2.72